CytoTronics

CytoTronics is a biotechnology company building next-generation complementary metal-oxide-semiconductor (CMOS)-driven drug discovery platforms. CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems. CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide-semiconductor (CMOS) electronic platform. CytoTronics' technology, based on a series of innovative technologies licensed from Harvard University, measures and manipulates living cells to generate real-time, high-resolution electrochemical and electrical cell-based assays.